对持续的职业接触抗生素药物和放射性核素的生物反应
Jelena Pajic1, Aleksandar P S Milovanovic2
1Serbian Institute of Occupational Health "Dr Dragomir Karajovic", Belgrade, Serbia.
International journal of radiation biology
|July 27, 2023
概括
职业接触抗瘤药物和放射性会增加遗传损伤. 过早的中间体分裂 (PCD) 被确定为暴露个体,特别是核医学工作者中基因毒性风险的关键指标.
科学领域:
- 细胞遗传学 细胞遗传学
- 职业健康 职业健康 职业健康
- 辐射生物学 辐射生物学
背景情况:
- 抗瘤药物和放射性是已知的职业危险.
- 暴露会影响遗传物质并导致染色体不稳定.
- 生物监测对于评估暴露工人的基因毒性风险至关重要.
研究的目的:
- 评估暴露于抗生素药物和放射性的个体的细胞遗传损伤.
- 评估染色体不稳定性作为职业暴露的生物标志物.
- 确定暴露人群中基因毒性风险的可靠指标.
主要方法:
- 一项涉及314名健康捐赠者的生物监测研究.
- 细胞遗传学分析使用染色体异常试验和细胞动力阻断微核 (CBMN) 试验.
- 对照组与暴露于抗瘤药物和放射性的组进行比较.
主要成果:
- 暴露组中观察到细胞遗传损伤的增加.
- 在暴露于抗瘤药物的受试者中,染色体断裂的发生率更高.
- 在核医学工作者中增加二心体和过早的中心体分裂 (PCD).
- 确定PCD是职业暴露的最佳预测因素.
- 年龄,性别,季节和暴露时间影响了结果,而吸烟则没有.
结论:
- 过早的中间体分裂 (PCD) 是基因毒性风险的有价值指标.
- 对于暴露于低剂量的电离辐射的人来说,PCD特别重要.
- 使用PCD进行生物监测可以帮助管理职业健康风险.
相关概念视频
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Types of Toxins
1.8K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.8K
Toxic Reactions: Overview
1.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K


